Clinical Research Directory
Browse clinical research sites, groups, and studies.
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
Sponsor: Baylor Research Institute
Summary
This single-center, open-label study will evaluate the safety and efficacy of subcutaneous heparin anticoagulation compared to the standard of care systemic intravenous anticoagulation during veno-venous extracorporeal membrane oxygenation for respiratory failure.
Official title: Single Center Open Label Randomized Study Evaluating Safety and Efficacy of Subcutaneous Heparin Compared to Standard of Care Intravenous Heparin Anticoagulation During Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2018-10-10
Completion Date
2026-06
Last Updated
2026-01-30
Healthy Volunteers
No
Conditions
Interventions
subcutaneous heparin anticoagulation
The primary objective of this study is to evaluate the safety and efficacy of subcutaneous heparin anticoagulation compared to the standard of care systemic intravenous anticoagulation during veno-venous extracorporeal membrane oxygenation for respiratory failure. Subjects will be prospectively randomized in 1:1 ratio to subcutaneous heparin anticoagulation or systemic intravenous anticoagulation and followed until 1 week after discontinuation from ECMO support.
Locations (1)
Baylor Scott & White Health research institute
Dallas, Texas, United States